Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1
Bourlière, Marc, Gordon, Stuart C, Schiff, Eugene R, Tran, Tram T, Ravendhran, Natarajan, Landis, Charles S, Hyland, Robert H, Stamm, Luisa M, Zhang, Jie, Dvory-Sobol, Hadas, Subramanian, G Mani, BraiLangue:
english
Journal:
The Lancet Gastroenterology & Hepatology
DOI:
10.1016/S2468-1253(18)30118-3
Date:
May, 2018
Fichier:
PDF, 99 KB
english, 2018
File converter
Plus de résultats de recherche
More benefits 
